ArticleCureus2023
Readmission Risk Assessment Tool (RRAT) for Decreasing 30-Day Readmission Rates in Total Joint Arthroplasty (TJA) and Predicting Readmission.
Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
- Healthcare-associated infection and unfavourable outcomes during a one-year follow-up after discharge: a single-center study.International journal of occupational medicine and environmental health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Total joint arthroplasty (TJA) has moved to a value-based care model that emphasizes increased quality and decreased costs. Preoperative patient selection and optimization significantly improve postoperative outcomes, improve quality, and decrease systemic costs. We introduced a readmission risk assessment tool (RRAT) previously verified in the literature at a large, private practice, multispecialty hospital to determine if implementation could improve outcomes and decrease our readmission rates. Methods All patients were administered the RRAT scoring tool prior to surgery. All staff was trained prior by a team consisting of multiple orthopedic surgeons, internal medicine and cardiac specialists, and anesthesiologists. If the score received by the patient was greater or equal to 4, a letter was sent immediately to the operative physician to work on optimization and a list of options for optimization was provided. No patients were expressly denied surgery. Results All 4912 patients from September 2017 to March 2020 were screened using the RRAT tool. A total of 228 patients had an RRAT score greater than 4 and required notification of the index surgeon. The overall readmission rate was 2.61% for all patients. We noted a readmission rate of 2.35% for those with a score of <4, 4.27% for those between 4-6, and 13.64% for those with a readmission rate >6. The odds ratio of those readmitted with an RRAT score >6 was 6.5488 (1.9080-22.4775, 95% CI). The American Society of Anesthesiologists (ASA) score and RRAT score were significantly correlated (Spearman Rho =0.324, P<0.001). Thirty-day readmission rates across the system decreased from 3.7% to 2.61% (p<0.05) when compared to the readmission rate in the year prior to the application of RRAT (September 2016 - August 2017). Conclusion The preoperative RRAT score is significantly correlated with 30-day readmission rates. Notification of the surgeon preoperatively of risk factors with modification options significantly lowered readmission rates in our study. Preoperative optimization leads to a decreased readmission rate and surgeon involvement is paramount to adherence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.